SPIN1 and autoimmune disease: Pld1 inhibitors reportedly promote Treg differentiation in vitro to improve the validation response in autoimmune diseases (51); the effect of Spin1 on the proliferation and migration of tumor cells has been demonstrated in most tumor studies whereas studies on immune function have been rarely reported.